Joseph E. Blais

720 total citations
37 papers, 375 citations indexed

About

Joseph E. Blais is a scholar working on Surgery, Economics and Econometrics and Cardiology and Cardiovascular Medicine. According to data from OpenAlex, Joseph E. Blais has authored 37 papers receiving a total of 375 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Surgery, 12 papers in Economics and Econometrics and 10 papers in Cardiology and Cardiovascular Medicine. Recurrent topics in Joseph E. Blais's work include Lipoproteins and Cardiovascular Health (9 papers), Health Systems, Economic Evaluations, Quality of Life (9 papers) and Pharmaceutical Economics and Policy (4 papers). Joseph E. Blais is often cited by papers focused on Lipoproteins and Cardiovascular Health (9 papers), Health Systems, Economic Evaluations, Quality of Life (9 papers) and Pharmaceutical Economics and Policy (4 papers). Joseph E. Blais collaborates with scholars based in Hong Kong, United Kingdom and China. Joseph E. Blais's co-authors include Esther W. Chan, Ian Chi Kei Wong, Wallis C. Y. Lau, Kenneth K. C. Man, Li Wei, Ruth Brauer, Vincent Ka Chun Yan, Celine Sze Ling Chui, Joseph Hayes and Tiantian Ma and has published in prestigious journals such as SHILAP Revista de lepidopterología, Annals of Internal Medicine and Journal of the American College of Cardiology.

In The Last Decade

Joseph E. Blais

32 papers receiving 369 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Joseph E. Blais Hong Kong	10	90	77	48	42	40	37	375
Boon Peng Lim Singapore	12	73 0.8×	115 1.5×	99 2.1×	62 1.5×	80 2.0×	24	586
Omar A. Almohammed Saudi Arabia	13	49 0.5×	56 0.7×	46 1.0×	78 1.9×	18 0.5×	71	606
Juan del Llano Spain	9	49 0.5×	63 0.8×	19 0.4×	35 0.8×	66 1.6×	15	471
Robert J. Lipsy United States	10	66 0.7×	38 0.5×	40 0.8×	44 1.0×	28 0.7×	19	399
Maria Giner‐Soriano Spain	11	39 0.4×	32 0.4×	100 2.1×	26 0.6×	20 0.5×	50	323
Stephen A. Goldman United States	7	43 0.5×	40 0.5×	73 1.5×	45 1.1×	32 0.8×	20	407
Katrin Farker Germany	10	77 0.9×	45 0.6×	43 0.9×	104 2.5×	23 0.6×	31	483
Smita Sontakke India	9	44 0.5×	21 0.3×	16 0.3×	49 1.2×	40 1.0×	28	304
Margaret L. Ackman Canada	13	96 1.1×	97 1.3×	301 6.3×	56 1.3×	45 1.1×	41	613
Teruo Tsuchiya Japan	12	32 0.4×	30 0.4×	24 0.5×	33 0.8×	24 0.6×	47	386

Countries citing papers authored by Joseph E. Blais

Since Specialization

Citations

This map shows the geographic impact of Joseph E. Blais's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Joseph E. Blais with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Joseph E. Blais more than expected).

Fields of papers citing papers by Joseph E. Blais

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Joseph E. Blais. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Joseph E. Blais. The network helps show where Joseph E. Blais may publish in the future.

Co-authorship network of co-authors of Joseph E. Blais

This figure shows the co-authorship network connecting the top 25 collaborators of Joseph E. Blais. A scholar is included among the top collaborators of Joseph E. Blais based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Joseph E. Blais. Joseph E. Blais is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Belančić, Andrej, et al.. (2025). Blood pressure effects of SGLT2 inhibitors and GLP‐1 receptor agonists: Mechanisms, trial evidence and Real‐world data. British Journal of Clinical Pharmacology.

Blais, Joseph E., Vincent Ka Chun Yan, Esther W. Chan, Ian Chi Kei Wong, & Eric Yuk Fai Wan. (2025). Safety and Effectiveness of Statins for Primary Prevention in Adults With Type 1 Diabetes. Journal of the American College of Cardiology. 86(11). 797–809.

Li, Xue, Angel Wong, Vincent Ka Chun Yan, et al.. (2025). Consumption and expenditure on fidaxomicin and oral vancomycin for Clostridioides difficile infection: A 12-year longitudinal study of 43 countries and regions. International Journal of Antimicrobial Agents. 67(1). 107664–107664.

Yu, Qiuyan, Joseph E. Blais, Eric Yuk Fai Wan, et al.. (2025). Primary prevention cardiovascular disease risk prediction model for contemporary Chinese (1°P-CARDIAC): Model derivation and validation using a hybrid statistical and machine-learning approach. PLoS ONE. 20(7). e0322419–e0322419. 1 indexed citations

Blais, Joseph E., et al.. (2025). Effectiveness and Safety of Statins in Type 2 Diabetes According to Baseline Cardiovascular Risk. Annals of Internal Medicine. 179(2). 157–167.

Yu, Qiuyan, Joseph E. Blais, Eric Yuk Fai Wan, et al.. (2024). Development and validation of risk prediction model for recurrent cardiovascular events among Chinese: the Personalized CARdiovascular DIsease risk Assessment for Chinese model. European Heart Journal - Digital Health. 5(3). 363–370. 3 indexed citations

Blais, Joseph E., Weixin Zhang, Yun Lin, et al.. (2023). Antibiotic use in hospitalized patients with COVID-19: a population-based study in Hong Kong. SHILAP Revista de lepidopterología. 3(1). e205–e205. 2 indexed citations

Blais, Joseph E., Xin Huang, & Jie Zhao. (2023). Overall and Sex-Specific Effect of Berberine for the Treatment of Dyslipidemia in Adults: A Systematic Review and Meta-Analysis of Randomized Placebo-Controlled Trials. Drugs. 83(5). 403–427. 11 indexed citations

Blais, Joseph E., Nicole Pratt, Jeff J. Guo, et al.. (2023). Impact of Introducing Infliximab Biosimilars on Total Infliximab Consumption and Originator Infliximab Prices in Eight Regions: An Interrupted Time-Series Analysis. BioDrugs. 37(3). 409–420. 6 indexed citations

10.

Pathadka, Swathi, Eric Yuk Fai Wan, Joseph E. Blais, et al.. (2022). Safety and effectiveness of low-dose aspirin for the prevention of gastrointestinal cancer in adults without atherosclerotic cardiovascular disease: a population-based cohort study. BMJ Open. 12(2). e050510–e050510. 8 indexed citations

11.

Ye, Xuxiao, Joseph E. Blais, V Ng, et al.. (2022). Association between statins and the risk of suicide attempt, depression, anxiety, and seizure: A population-based, self-controlled case series study. Journal of Affective Disorders. 320. 421–427. 4 indexed citations

12.

Blais, Joseph E., Xuxiao Ye, Eric Yuk Fai Wan, et al.. (2022). Effectiveness of Simvastatin Versus Gemfibrozil for Primary Prevention of Cardiovascular Events: A Retrospective Cohort Study of 223,699 Primary Care Patients. Clinical Drug Investigation. 42(11). 987–997. 4 indexed citations

13.

Chen, Esa Y. H., Jenni Ilomäki, Janet K. Sluggett, et al.. (2022). Medication Regimen Complexity and Risk of Bleeding in People Who Initiate Oral Anticoagulants for Atrial Fibrillation: A Population-Based Study. The Journals of Gerontology Series A. 78(3). 470–478. 2 indexed citations

14.

Ye, Xuxiao, Tiantian Ma, Joseph E. Blais, et al.. (2022). Association between BNT162b2 or CoronaVac COVID-19 vaccines and major adverse cardiovascular events among individuals with cardiovascular disease. Cardiovascular Research. 118(10). 2329–2338. 19 indexed citations

15.

Blais, Joseph E., et al.. (2021). Comparative efficacy and safety of statin and fibrate monotherapy: A systematic review and meta-analysis of head-to-head randomized controlled trials. PLoS ONE. 16(2). e0246480–e0246480. 7 indexed citations

16.

Wei, Yue, Ian Chi Kei Wong, Eric Yuk Fai Wan, et al.. (2021). Relation of substance use disorders to mortality, accident and emergency department attendances, and hospital admissions: A 13-year population-based cohort study in Hong Kong. Drug and Alcohol Dependence. 229(Pt B). 109119–109119. 7 indexed citations

17.

Weng, Stephen, Ralph Kwame Akyea, Kenneth K. C. Man, et al.. (2021). Determining propensity for sub-optimal low-density lipoprotein cholesterol response to statins and future risk of cardiovascular disease. PLoS ONE. 16(12). e0260839–e0260839. 4 indexed citations

18.

Blais, Joseph E., Yue Wei, Hassan Alwafi, et al.. (2021). Trends in lipid-modifying agent use in 83 countries. Atherosclerosis. 328. 44–51. 70 indexed citations

19.

Blais, Joseph E., Ralph Kwame Akyea, Wallis C. Y. Lau, et al.. (2020). Lipid levels and major adverse cardiovascular events in patients initiated on statins for primary prevention: an international population-based cohort study protocol. BJGP Open. 5(1). bjgpopen20X101127–bjgpopen20X101127. 3 indexed citations

20.

Blais, Joseph E., Esther W. Chan, Michael Mok, et al.. (2018). Trends in statin prescription prevalence, initiation, and dosing: Hong Kong, 2004–2015. Atherosclerosis. 280. 174–182. 24 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact